Table 2.

Review of Staphylococcus aureus positive stool cultures from 1/2014–10/2020^*.

Age group (years)	Biofire	Discharge diagnosis by clinician	Comorbidities during diagnosis	Imaging	Antibiotics	Outcome
5–10	Norovirus	Norovirus	none	none	none	Outpatient
20–29	Negative	Laxative-induced	none	none	none	Outpatient
30–39	Negative	Neutropenic enterocolitis (S. aureus not contributory)	Relapsed metastatic neuroblastoma status-post autologous hematopoietic stem cell transplant complicated by febrile neutropenia	CT: small bowel thickening	Vancomycin IV, cefepime IV, metronidazole IV	Discharged home with resolution
30–39	Campylobacter	Campylobacter	none	none	Azithromycin	Outpatient
30–39	Negative	Laxative-induced	Diabetic ketoacidosis, Staphylococcus aureus bacteremia complicated by epidural abscess and sepsis	none	Vancomycin IV	Discharged home with resolution
50–59	Negative	Neutropenic enterocolitis (S. aureus not contributory)	Myelodysplastic syndrome status-post allogeneic hematopoietic stem cell transplant complicated by febrile neutropenia	CT: small bowel thickening	Vancomycin IV, cefepime IV, metronidazole IV	Discharged home with resolution
70–79	Negative	Neutropenic enterocolitis (attributed to S. aureus)	Acute myelogenous leukemia status-post induction chemotherapy complicated by febrile neutropenia, clinically quiescent Crohn's disease	CT: small bowel thickening and dilatation, pneumatosis	Piperacillin-tazobactam, vancomycin IV, vancomycin PO	Died of septic shock secondary to MRSA enterocolitis with severe neutropenia

^⁎Cultures obtained at the University of Washington Medical Center and Seattle Cancer Care Alliance.